Helicobacter pylori infection in coronary artery disease

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 3, 2006, Pages 101-111

  Kowalski, M ^a   Pawlik, M ^b   Konturek, J W ^c   Konturek, S J ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c Department of Gastroenterology ^*  (Germany)

Author keywords

Atherosclerosis; Coronary artery disease; Cytokines; Helicobacter pylori; Restenosis

Indexed keywords

BACTERIAL DNA; CYTOKINE; IMMUNOGLOBULIN G;

ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIUM DETECTION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; HELICOBACTER INFECTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; REVIEW; SEROPREVALENCE;

CORONARY ARTERY DISEASE; CORONARY VESSELS; DNA, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 33750289637     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843.
2. Mendall M, Goggin P, Levy J, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71:437-439.
3. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet, 1997; 350: 430-436.
4. Danesh J, Wong Y, Ward M, et al. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or Cytomegalovirus: population based study of coronary heart disease. Heart 1999; 81: 245-247.
5. Glynn J. Helicobacter pylori and the heart. Lancet 1994; 344: 146.
6. Pellicano R, Mazzarello MG, Morelloni S, et al. Acute myocardial infarction and Helicobacter pylori seropositivity. Int J Clin Lab Res 1999; 29: 141-144.
7. Danesh J, Youngmann L, Clark S, et al. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. Br Med J 1999; 319:,1157-1162.
8. Singh RK, McMahon AD, Patel H, et al. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart 2002; 88: 43-46.
9. Pasceri V, Caramota G, Patti G, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998; 97: 1675-1679.
10. Niemela S, Karttunen T, Korhonen T, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996; 75: 373-375.
11. de Luis DA, Garcia-Avello A, Lasuncion MA, et al. Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. Clin Nutr 1999; 18 (4) :227-231.
12. Hoffmeister A, Rothenbacher D, Bode G, et al. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or Cytomegalovirus, is associated with atherigenic, modified lipid profile. Arterioscler Thromb Vasc Biol 2001; 21: 427-432.
13. Pienia̧żek P, Karczewska E, Duda A, et al. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol 1999; 50(5): 743-751.
14. Pellicano R, Broutet N, Ponzetto A, et al. Helicobacter pylori: from the stomach to the heart. Eur J Gastroenterol-Hepatol 1999; 11(11): 1335-1337.
15. Abdelmouttaleb T, Dauchin N, Ilardo C. et al. C-reactive protein and coronary artery disease additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999; 137: 346-351.
16. Gasbarrini A, Franceschi F, Cammarota G, et al. Vascular and immunological disorders associated with Helicobacter pylori infection. Ital J Gastroenterol Hepatol 1998; 30: 115-118.
17. Stone AF, Mendall MA. Helicobacter pylori is an ethiological factor for ischemic heart disease: the case in favour. Digest Liver Dis 2000; 32: 62-64.
18. Mendall MA, Patel P, Ballam L, et al. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 1996; 312: 1061-1065.
19. Murray LJ, Bamford KB, O'Reilly DP, et al. Helicobacter pylori infection: relation with cardiovascular risk factors, ischemic heart disease, and social class. Br Heart J 1995; 74: 497-501.
20. Birnie DH, Holme ER, McKay IC, et al. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998; 19: 387-394.
21. Franceschi F, Sepulveda AR, Gasbarrini A, et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002; 106: 430-434.
22. Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997; 78: 273-277.
23. Kowalski M, Konturek JW, Konturek SJ, et al. Helicobacter pylori infection - a new cardiovascular risk factor? Book of Abstracts: 7th World Congress of Cardiac Rehabilitation and Secondary Prevention- Manilla, 2000; A03.
24. Kowalski M, Konturek JW, Kluczka A, Nasseri R. Incidence of infection with Helicobacter pylori (HP) in patients with coronary artery disease. J Physiol Pharmacol 1999; 50 ( Suppl 2): A28.
25. Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 2001; 52 (Suppl. 1): 3-31.
26. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. Br Med J 1997; 315: 1199-1201.
27. Strachan DP, Mendall MA, Carrington D, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischaemic heart disease in the caerphilly prospective heart disease study. Circulation 1998; 98: 286-290.
28. Tsai CJ, Huang TY. Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease. Dig Dis Sci 2000; 45: 1227-1232.
29. Bielanski W. Epidemiological study on Helicobacter pylori infection and extragastroduodenal disorders in Polish population. J Physiol Pharmacol 1999; 50: 723-733.
30. Biagi P, Fabbrini D, Bocchini S. Seroprevalence of Helicobacter pylori infection in a group of hospitalized geriatric patients. Panminerva Med 2000; 42: 183-186.
31. Gunn M, Stephens JC, Thomason JR, et al. Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000; 84: 267-271.
32. Pellicano R, Parravicini PP, Bigi R, et al. Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference? New Microbiol 2002; 25: 315-321.
33. Stone AF, Risley P, Markus HS. Ischaenic heart disease and CagA strains of Helicobacter pylori in the Caerphilly heart disease study. Heart 2001; 86: 506-509.
34. Whincup P, Danesh J, Walker M, et al. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000; 101: 1647-1652.
35. König H, P Rothenbacher, A Hoffmeister, et al. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation 1999; 100: 2326-2331.
36. Rothenbacher D, Hoffmeister A, Bode G, at al. Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids. Atherosclerosis 2001; 156: 193-199.
37. Brunec M, Kowalski M, Kranig W, et al. Influence of Helicobacter pylori - infection on restenosis rate in patients after PTCA - A new goal to secondary prevention. 8th Alpe Adria Cardiology Meeting 2000 - Abstract Book 2000; A140.
38. Carlsson J, Miketic S, Brom J, et al. Prior Cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneus transluminal coronary angioplasty. Int J Cardiol 2000; 28: 72:165-171.
39. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.
40. Xu Q, Schett G, Perschinka H, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000; 102: 14-20.
41. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. Circulation 1997; 96: 4095-4103.
42. Blasi F, Denti F, Erba M, et al. Detection of Chlamydia pneumoniae but not H. pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996; 34: 2766-2769.
43. Farsak B, Yildirir A, Akyön Y, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000; 38: 4408-4411.
44. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001; 32: 385-391.
45. Kowalski M, Konturek PC, Pieniazek P, et al. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Digest Liver Dis 2001; 33: 222-229.
46. Konturek PC, Bielanski W, Konturek SJ, Hahn EG. Helicobacter pylori associated gastric pathology. J Physiol Pharmacol 1999; 50: 695-710.
47. Yusuf SW, Mishra RM. Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease. Acta Cardiol 2002; 57: 317-322.
48. Stone AF, Mendall MA, Kaski JC, et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation 2002; 106: 1219-1223.
49. Schweeger I, Fitscha P, Sinzinger H. Successful eradication of Helicobacter pylori as determined by 13C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res 2000; 97: 411-420.
50. Lu YH, Yen HW, Lin TH, et al. Changes of coronary risk factors after eradication of Helicobacter pylori infection. Kaohsiung J Med Sci 2002; 18: 266-272.
51. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199-204.